GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Epitomee Medical Ltd (XTAE:EPIT) » Definitions » EV-to-EBIT

Epitomee Medical (XTAE:EPIT) EV-to-EBIT : 0.11 (As of May. 27, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Epitomee Medical EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Epitomee Medical's Enterprise Value is ₪-2.24 Mil. Epitomee Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₪-20.67 Mil. Therefore, Epitomee Medical's EV-to-EBIT for today is 0.11.

The historical rank and industry rank for Epitomee Medical's EV-to-EBIT or its related term are showing as below:

XTAE:EPIT' s EV-to-EBIT Range Over the Past 10 Years
Min: -0.01   Med: 0.54   Max: 1.26
Current: 0.11

During the past 6 years, the highest EV-to-EBIT of Epitomee Medical was 1.26. The lowest was -0.01. And the median was 0.54.

XTAE:EPIT's EV-to-EBIT is ranked better than
98.01% of 452 companies
in the Medical Devices & Instruments industry
Industry Median: 20.2 vs XTAE:EPIT: 0.11

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Epitomee Medical's Enterprise Value for the quarter that ended in Dec. 2023 was ₪-3.70 Mil. Epitomee Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₪-20.67 Mil. Epitomee Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 559.08%.


Epitomee Medical EV-to-EBIT Historical Data

The historical data trend for Epitomee Medical's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epitomee Medical EV-to-EBIT Chart

Epitomee Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial - - -21.64 -3.27 0.16

Epitomee Medical Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only -21.64 - -3.27 - 0.16

Competitive Comparison of Epitomee Medical's EV-to-EBIT

For the Medical Devices subindustry, Epitomee Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Epitomee Medical's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Epitomee Medical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Epitomee Medical's EV-to-EBIT falls into.



Epitomee Medical EV-to-EBIT Calculation

Epitomee Medical's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=-2.242/-20.67
=0.11

Epitomee Medical's current Enterprise Value is ₪-2.24 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Epitomee Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₪-20.67 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Epitomee Medical  (XTAE:EPIT) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Epitomee Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-20.67/-3.6971696
=559.08 %

Epitomee Medical's Enterprise Value for the quarter that ended in Dec. 2023 was ₪-3.70 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Epitomee Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₪-20.67 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Epitomee Medical EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Epitomee Medical's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Epitomee Medical (XTAE:EPIT) Business Description

Traded in Other Exchanges
Address
Tarshish 19, Caesarea, ISR, 3088900
Epitomee Medical Ltd is engaged in developing and commercializing ingestible therapeutic devices.

Epitomee Medical (XTAE:EPIT) Headlines

No Headlines